Morning Briefing
Summaries of health policy coverage from major news organizations
U.S. Joins Whistleblower Suit Against Pfizer For Drug Marketing
The U.S. Justice department is joining a whistleblower suit against Pfizer for off-label marketing of a drug.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
